Friday, August 17, 2018 5:41:38 PM
"The JV is scheduled to close at the end of the month. If we can close it, that’s $4M to market and distribute Nyloxin. This will certainly result in stock appreciation.
We’re still seeing steady shorting as they don’t see any activity in the company right now. Any positive news will stabilize the stock price and may see short coverage that can only help.
However you slice it, we’re undervalued at these levels. We should be trading much higher, and the JV will allow us to realize those improved market values."
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM